Children With Rare Neurogenerative Disorder Will Undergo Phase I Clinical Trial Using Stem Cells
Children and infants with a rare neurodegenerative disorder, will undergo a Phase I clinical trial using stem cells at Doernbecher Children’s Hospital, Oregon Health & Science University.
This trial will test if:
1. HuCNS-SC(TM), a proprietary human central nervous stem cell product developed by Stem Cells, Inc. is safe or not.
2. It can slow the progression of two forms of neuronal ceroid lipofuscinosis (NCL).
Read more on The Stem Cell Blog
Filed under Health, Stem Cell Research
You may also like to read
- Trial for Purified Neural Stem Cell Transplantation Begins
- Phase-II Clinical Trial of Drug Evizon for Wet Age-Related Macular Degeneration
- Kids could recover from brain tumour through exercise
- Stem Cell Trial For Heart Patients in UK
- Researchers to investgate for un related bone marrow to treat sickle cell patients
